Remote site control of an active site fidelity checkpoint in a viral RNA-dependent RNA polymerase by Arnold, J.J. et al.
Remote Site Control of an Active Site Fidelity Checkpoint in a
Viral RNA-dependent RNA Polymerase*
Received for publication, March 30, 2005, and in revised form, April 25, 2005
Published, JBC Papers in Press, May 5, 2005, DOI 10.1074/jbc.M503444200
Jamie J. Arnold‡, Marco Vignuzzi§, Jeffrey K. Stone§, Raul Andino§, and Craig E. Cameron‡¶
From the ‡Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park,
Pennsylvania 16802 and the §Department of Microbiology and Immunology, University of California,
San Francisco, California, 94143
The kinetic, thermodynamic, and structural basis for
fidelity of nucleic acid polymerases remains controver-
sial. An understanding of viral RNA-dependent RNA po-
lymerase (RdRp) fidelity has become a topic of consid-
erable interest as a result of recent experiments that
show that a 2-fold increase in fidelity attenuates viral
pathogenesis and a 2-fold decrease in fidelity reduces
viral fitness. Here we show that a conformational
change step preceding phosphoryl transfer is a key fi-
delity checkpoint for the poliovirus RdRp (3Dpol). We
provide evidence that this conformational change step
is orientation of the triphosphate into a conformation
suitable for catalysis, suggesting a kinetic and struc-
tural model for RdRp fidelity that can be extrapolated to
other classes of nucleic acid polymerases. Finally, we
show that a site remote from the catalytic center can
control this checkpoint, which occurs at the active site.
Importantly, similar connections between a remote site
and the active site exist in a wide variety of viral RdRps.
The capacity for sites remote from the catalytic center
to alter fidelity suggests new possibilities for targeting
the viral RdRp for antiviral drug development.
During each cycle of nucleotide incorporation, nucleic acid
polymerases are presented with the challenge of having to
select a nucleotide with the correct sugar configuration and the
correct base. Fidelity of nucleotide selection is essential for
maintenance of the information content and accurate expres-
sion of the genome. Importantly, some level of incorrect incor-
poration must exist to provide a mechanism for all organisms to
survive challenges imposed by nature. Elucidation of the mech-
anisms employed by polymerases to maintain the appropriate
balance between correct and incorrect nucleotide incorporation
has been a primary goal of polymerase enzymology and struc-
tural biology.
The single nucleotide-addition cycle of polymerases is likely
conserved, consisting of at least five kinetically observable
steps: 1) nucleotide binding; 2) a conformational change; 3)
phosphodiester bond formation; 4) a second conformational
change, perhaps translocation; and 5) pyrophosphate release
(1–7). Theoretically, any of these steps could be employed as
fidelity checkpoints. Empirically, the first three steps appear to
be the primary steps governing fidelity of nucleotide addition
(1–7). However, there is considerable debate regarding the
capacity of the first conformational change step to act as a
fidelity checkpoint (8, 9). Further complicating matters is the
absence of a clear structural explanation for the conformational
change observed kinetically. Structural explanations range
from inter- and intra-domain rearrangements (10–12) to
triphosphate reorientation (1, 7, 13–17).
Studies of viral DNA-dependent DNA and RNA polymerases
have been essential to developing the current state-of-the-art
for polymerase structure, function, and mechanism. However,
until recently, very little structural and mechanistic informa-
tion existed for the viral RNA-dependent RNA polymerase
(RdRp)1 (7, 17–22). Fidelity of RNA virus polymerases has
become a topic of increased clinical importance, because the
capacity for RNA virus populations to escape neutralization by
the immune system and to develop resistance to antiviral
agents is a direct consequence of errors introduced by the
polymerase during genome replication. Even more intriguing,
however, are the recent realizations that very subtle increases
in RdRp fidelity can attenuate viral pathogenesis 2 and very
subtle decreases in polymerase fidelity can force the virus into
error catastrophe (lethal mutagenesis) (24).
The RdRp from poliovirus (PV), 3Dpol, has emerged as an
important model system for understanding the structure, func-
tion, and mechanism of this class of polymerases (7, 17–22, 25).
However, given the structural and mechanistic similarities of
3Dpol to DNA polymerases, RNA polymerases, and reverse
transcriptases (7, 21, 22), it is likely that the structural and
mechanistic basis for 3Dpol fidelity will be relevant to all classes
of nucleic acid polymerases. Although it is often suggested that
the RdRp has a high error rate, the RdRp error rate is actually
equivalent to replicative DNA polymerases in the absence of
the proofreading exonuclease (7).
In this report, we describe a PV mutant (G64S PV) that is
less sensitive to an antiviral nucleoside yet more sensitive to
other classes of antiviral compounds due to a mutation in
3Dpol-coding sequence that restricts genomic diversity. We
show that this polymerase derivative, G64S 3Dpol, has a higher
fidelity than the wild-type enzyme owing to a change in the
equilibrium constant for the conformational change step pre-
ceding the chemical step. Although position 64 is remote from
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the active site, the backbone of this residue is connected via
hydrogen bonding to the conserved structural motif A that
functions, in part, to hold the triphosphate of the incoming
nucleotide in a conformation appropriate for catalysis. Impor-
tantly, similar connections between remote sites and motif A
exist in polymerases from a wide variety of RNA viruses. To-
gether, these data provide genetic evidence for a role of the first
conformational change step in polymerase fidelity, provide a
link between the conformational change and the orientation of
the triphosphate of the incoming nucleotide, and define sites
remote from the polymerase active site as targets for develop-
ment of antiviral agents capable of functioning by modulating
nucleotide incorporation fidelity. The conclusions of this study
regarding fidelity mechanisms employed by the RdRp are ger-
mane to all classes of nucleic acid polymerases.
EXPERIMENTAL PROCEDURES
Materials—[-32P]ATP (7000 Ci/mmol) was from ICN; [-32P]UTP
was from New England Nuclear; nucleoside 5-triphosphates (all nucle-
otides were ultrapure solutions) and adenosine 5-O-(1-thiotriphos-
phate) were from Amersham Biosciences; dT15 was from Integrated
DNA Technologies, Inc.; poly(rA) was from Sigma; RNA oligonucleo-
tides were from Dharmacon Research, Inc. (Boulder, CO); T4 polynu-
cleotide kinase was from New England Biolabs, Inc.; All other reagents
were of the highest grade available from Sigma or Fisher.
Cells, Viruses, and Plasmids—HeLa S3 cells (ATCC CCL 2.2) were
grown in tissue culture flasks in Dulbecco’s modified Eagle’s medium-
nutrient mixture F-12 (Ham’s, 1:1, CellGro), supplemented with 2 mM
L-glutamine, 1 mM sodium pyruvate, 100 units of penicillin and strepto-
mycin per milliliter, and 10% newborn calf serum (Invitrogen). Wild-type
(WT) poliovirus type 1 Mahoney was used throughout this study. Plasmid
prib()XpA (hereupon referred to as pXpA) contains the cDNA of polio-
virus preceded by the hammerhead ribozyme and the T7 RNA polymerase
promoter permitting the generation of infectious synthetic RNAs.
Construction of Recombinant G64S PV Clone—The codon encoding
Gly-64 of the poliovirus RdRp was changed to Ser in the cDNA of WT
poliovirus type 1 Mahoney in the plasmid pXpA. Specifically, nucleo-
tides 6746–6748 (GGT) were mutagenized to TCA using appropriate
primers (available upon request) and the QuikChange Mutagenesis
XLII kit (Stratagene). Positive clones were identified and confirmed by
sequencing. The resulting plasmid pG64S permits the transcription of
infectious full-length genomes, expressing the mutant G64S polymerase.
In Vitro Transcription and RNA Transfection—Poliovirus tran-
scripts corresponding to full-length genomic RNA (pXpA or pG64S)
were obtained using a T7 Megascript transcription kit (Ambion) after
linearization of cDNA plasmids. The integrity of the resulting RNAs
was confirmed by gel electrophoresis. Transfection of HeLa S3 cells
with these synthetic RNAs was performed with an Electro Cell Manip-
ulator600 (BTX) following the manufacturer’s directions.
Effect of Ribavirin on Virus Titer—HeLa S3 cells were infected at an
multiplicity of infection of 0.1 with either passage 3 WT poliovirus (P3)
or passage 3 G64S virus in the presence of 0–1000 M ribavirin. Upon
total cell lysis (cytopathic effect), virus was recovered and titered by
plaque assay.
WIN Compound Escape Mutants Assay—WIN 51711 (disoxaril) com-
pound and the assay protocol were obtained as a kind gift from Dan
Pevear, ViroPharma, Inc. Survival curves were established by plating
serial 10-fold dilutions of 106 plaque-forming units/ml virus stocks on
duplicate HeLa S3 cell monolayers in 6-well plates. After a 1-h adsorp-
tion period the inoculum was removed and 3 ml of overlay medium was
added containing 1.0% agarose and different concentrations of disoxaril
(10 M, 1 M, 0.1 M, 0.01 M, or no drug). Percent inhibition was
plotted as a function of virus titer obtained at each concentration of
WIN compound over control titer obtained with mock treatment.
RNA Isolation, cDNA Synthesis, and Sequencing—Eighteen viral
isolates belonging to each of the WT and G64S populations were ob-
tained by plaque isolation. The viral isolates were then replicated on
fresh HeLa cell monolayers (in 24-well plates) for 6 h, and viral RNA
was extracted and purified by TRIzol extraction. RT-PCR was per-
formed on the RNA using the Thermoscript kit (Invitrogen) and Pfu
ultrafidelity polymerase (Stratagene). The RT reaction was performed
using the oligo-dT primer. Two PCR products were obtained for each
viral isolate, a product spanning the 5-untranslated region and capsid
coding region (nt 300–3300) and a product spanning 3CD and the
3-untranslated region (nt 5800–7441). Primers for the 5-product were
5-CAGAGTGTAGCTTAGGC-3 (forward) and 5-GGTGGACGCGG-
GCACC-3 (reverse). Primers for the 3-product were 5-CAGGGAT-
ATCTAAATCTC-3 (forward) and 5-CTCCGAATTAAAGAAAAATT-
TACCC-3 (reverse). The 36 PCR fragments from each population,
representing 18 different viral clones of either WT or G64S, were
purified using a Qiagen PCR purification kit and sequenced.
Virus Competition Experiment—HeLa cells were plated in 10-cm2
dishes and infected at an multiplicity of infection of 10 with a virus
mixture composed of passage 0 WT and G64S viruses at a ratio of 1:10.
After adsorption, input virus was removed, and infection was allowed to
proceed to cell lysis. Virus from the supernatants of infected cells was
harvested by three freeze-thaw cycles and used to re-infect fresh HeLa
monolayers (passages 1–3). At each passage, viral RNA was extracted
by treatment with TRIzol-HCl for reverse transcription-PCR. Reverse
transcription-PCR was performed as above, using the same primers
that amplified the 3-product. Direct sequencing of the PCR product
was performed to determine the proportion of progeny virus belonging
to the WT or G64S populations.
Construction of G64S Expression Vector—The G64S expression vec-
tor was constructed by introducing the G64S-encoding mutation into
the WT 3Dpol coding sequence by using overlap extension PCR with the
appropriate primers (available upon request) and subcloning into the
pET26-Ub-3D expression plasmid essentially as described previously
(26). Mutations were confirmed by DNA sequencing (Nucleic Acid Fa-
cility, Pennsylvania State University).
Expression and Purification of 3Dpol—Expression and purification of
3Dpol WT and G64S were performed as described previously (26).
Purification, 5-32P Labeling, and Annealing of sym/sub—RNA oli-
gonucleotides were purified, labeled, and annealed as described previ-
ously (18).
Poly(rU) Polymerase Specific Activity Assay—Reactions contained 50
mM HEPES, pH 7.5, 10 mM 2-mercaptoethanol, 5 mM MgCl2, 0.05 M
3Dpol, 500 M UTP, 0.2 Ci/l [-32P]UTP, 1.88 M dT15, and poly(rA)
(93.4 M AMP). Reactions were initiated by 3Dpol and incubated at
30 °C for 5 min at which time the reactions were quenched by addition
of EDTA to a final concentration of 50 mM. Products were analyzed by
DE81 filter binding as previously described (27).
sym/sub Assays—Reactions contained 50 mM HEPES, pH 7.5, 10 mM
2-mercaptoethanol, 5 mM MgCl2 or 5 mM MnCl2, 500 M NTP, sym/sub,
and 3Dpol. Reactions were either quenched by addition of EDTA to a
final concentration of 0.3 M or by addition of HCl to a final concentration
of 1 M. Immediately after addition of HCl, the solution was neutralized
by addition 1 M KOH and 300 mM Tris (final concentration). Specific
concentrations of primer/template and 3Dpol, along with any deviations
from the above, are indicated in the appropriate figure legend. 3Dpol
was diluted immediately prior to use in 50 mM HEPES, pH 7.5, 10 mM
2-mercaptoethanol, and 20% glycerol. The volume of enzyme added to
any reaction was always less than or equal to one-tenth the total
volume. All reactions were performed at 30 °C.
Rapid Chemical Quenched Flow Experiments—Rapid mixing/
quenching experiments were performed by using a Model RQF-3 chem-
ical-quench-flow apparatus (KinTek Corp., Austin, TX). Experiments
were performed at 30 °C by using a circulating water bath. 3Dpol-sym/
sub complexes were assembled by mixing 3Dpol and sym/sub for 3 min
at room temperature and then rapidly mixed with the nucleotide sub-
strate. After mixing, reactant concentrations were reduced by 50%.
Reactions were either quenched by addition of EDTA to a final concen-
tration of 0.3 M or by addition of HCl to a final concentration of 1 M
followed by immediate neutralization.
Determination of the Kinetic Parameters (kpol and Kd,app) for 3D
pol-
catalyzed Nucleotide Incorporation—3Dpol (2 M) was incubated with
sym/sub (1 M duplex) and rapidly mixed with varying concentrations of
nucleotide substrate (1/5  Kd,app to 5  Kd,app). At various times after
mixing, reactions were either quenched by addition of EDTA or HCl.
Time courses at fixed nucleotide concentration were fit to Equation 1,
[Product]  A*ekobs*t  C (Eq. 1)
where A is the amplitude of the burst, kobs is the observed first-order
rate constant describing the burst, t is the time, and C is a constant. The
observed rate constants were plotted as a function of nucleotide con-





where kpol is the maximal observed rate constant for nucleotide incor-
poration and Kd,app is the apparent dissociation constant. Data were fit
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by non-linear regression using the program KaleidaGraph (Synergy
Software, Reading, PA).
Kinetic Simulation—Kinetic simulations were performed by using
KinTekSim Version 2.03 (KinTek Corp., Austin, TX). Schemes em-
ployed are provided as figures. All rate constants were determined
experimentally, except where noted. The agreement between the exper-
imental data and kinetic simulations was determined by visual
inspection.
RESULTS
G64S PV Population Has Reduced Genomic Diversity—The
genomic diversity of RNA virus populations permits rapid ad-
aptation of the population to environmental stresses. Maximal
adaptability requires maximal genomic diversity. However, the
consequence of maximal genomic diversity is susceptibility to
extinction under conditions in which a subtle increase in mu-
tation frequency occurs. This mutation-induced extinction has
been termed lethal mutagenesis, a promising broad spectrum
antiviral strategy (28–33). Studies with PV have shown that
the mechanism of action of ribavirin, a clinically useful antivi-
ral nucleoside, is lethal mutagenesis (24). The PV RdRp can
incorporate ribavirin triphosphate ambiguously into the ge-
nome, forcing the virus population into error catastrophe (24).
One mechanism of resistance to nucleoside-based mutagens is
enhanced RdRp fidelity. Isolation of such a mutant would pro-
vide significant insight not only into the importance of genomic
diversity for viral infectivity and pathogenesis but also into
mechanisms of fidelity employed by polymerases.
Serial passage of PV in the presence of ribavirin yields a
mutant with reduced sensitivity to ribavirin (34).2 This mutant
contains a single nucleotide substitution in 3Dpol-coding se-
quence that converts Gly-64 to Ser. A recombinant G64S PV
was constructed to preclude genetic reversion. As shown in Fig.
1A, in the absence of ribavirin, this virus grows to titers equiv-
alent to WT PV, suggesting that this mutation does not alter
the fitness of the virus in tissue culture. As the concentration of
ribavirin is increased, G64S PV exhibits reduced sensitivity to
the drug (Fig. 1A).
FIG. 1. Biological analysis of G64S PV. A, the G64S substitution
confers resistance to ribavirin. Titer of surviving virus (plaque-forming
units/ml) at 20 h post-infection for WT PV (●) and G64S PV (E) in the
presence of increasing concentrations of ribavirin. B, the G64S PV
population contains a reduced number of drug-resistant variants. Per-
centage of inhibition for WT PV (f) and G64S PV () in the presence of
increasing concentrations of WIN 51711 (disoxaril). Error bars indicate
variance between two separate experiments. C, the G64S virus popu-
lation exhibits a reduced mutation frequency. The total number of
mutations observed per 36,000 nucleotides sequenced and the calcu-
lated average number of mutations per genome are shown. The muta-
tion frequencies of the virus populations were found to be statistically
different (p  0.04799) by Mann-Whitney U test.
FIG. 2. G64S 3Dpol has a faster inactivation rate that leads to
reduced activity on homopolymeric substrates and reduced as-
sembly on a heteropolymeric primer-template substrate. A, in-
activation of 3Dpol. Percentage of active WT 3Dpol (●) and G64S 3D pol
(E) remaining plotted as a function of time. The solid lines represent the
fit of the data to a single exponential with a kinact(obs) of 5.6  0.7  10
3
s1 for WT 3Dpol and 5.1  0.2  102 s1 for G64S 3Dpol. 3Dpol (2 M)
was incubated in 1 reaction buffer with ATP (500 M) at 30 °C, and at
the indicated times the reaction was initiated by addition of sym/sub
(0.5 M duplex) and allowed to proceed for an additional 90 s at which
point the reaction was quenched by addition of EDTA. B, specific
activity (picomoles/min/g) for WT 3Dpol and G64S 3Dpol on oligo(dT)-
primed poly(rA). Reactions were performed as described under “Exper-
imental Procedures.” C, primer/template (sym/sub-U) employed. Sub-
strate (10-mer) can be resolved from product(s) by denaturing PAGE
and visualized by phosphorimaging. D, WT 3Dpol and G64S 3Dpol as-
semble on and utilize sym/sub-U. Kinetics of assembly on and utiliza-
tion of sym/sub-U by WT 3Dpol (●) and G64S 3D pol (E). Product (11-mer)
formed in panel C plotted as a function of time. The solid lines represent
the fit of the data to a single exponential with an observed rate constant
of 0.017  0.001 s1 and an amplitude of 0.27  0.01 M for WT 3Dpol
and an observed rate constant of 0.050  0.007 s1 and an amplitude of
0.11  0.01 M for G64S 3Dpol. Reactions contained 3Dpol (1 M),
sym/sub (0.5 M duplex), and ATP (500 M). Reactions were initiated by
3Dpol.
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PV and other entero- and rhinoviruses in the Picornavirus
family are sensitive to a class of inhibitors, commonly called
WIN compounds, that inhibit virus uncoating by binding to the
mature virus capsid and preventing conformational changes
required for uncoating (9, 35, 36). Resistance to some of these
compounds, for example WIN 51711 (disoxaril), rapidly
emerges owing to the existence of drug-resistant variants in
the virus population (9, 36). WT PV resists challenge by WIN
51711 over a wide concentration range (Fig. 1B), likely reflect-
ing drug-resistant mutants in the population. If G64S PV en-
codes a polymerase with enhanced fidelity, then fewer drug-
resistant variants should be present in this population,
conferring enhanced sensitivity of G64S PV to WIN 51711. As
shown in Fig. 1B, G64S PV is more sensitive to WIN 51711. To
confirm that the diversity of the G64S PV population was re-
duced relative to WT PV, we sequenced 36,000 nt of capsid-
coding sequence. The G64S PV population contains 4-fold fewer
mutations per genome than the WT PV population (Fig. 1C).
These results are consistent with enhanced fidelity of G64S 3Dpol
mediating the reduced sensitivity of G64S PV to ribavirin.
Biochemical Defects Associated with G64S 3Dpol—We ex-
pressed and purified G64S 3Dpol and compared its basic bio-
chemical properties to WT 3Dpol (26). At temperatures greater
than 4 °C, WT 3Dpol has a finite lifetime in solution in the
absence of nucleotide and nucleic acid (Fig. 2A) (18). The ob-
served rate constant for inactivation of G64S 3Dpol at 30 °C in
the presence of 500 M ATP is 9-fold faster than WT 3Dpol (Fig.
2A). The faster rate of inactivation of G64S 3Dpol leads to a
15-fold reduction in the specific activity of this derivative rel-
ative to WT enzyme as determined by using a poly(rU) polym-
erase activity assay (Fig. 2B). Product formed by using this
assay reflects template-switching activity of the few complexes
that assemble productively on this primer-template substrate
(27). An increase in the rate constant for inactivation will cause
a proportional reduction in complexes competent for primer
extension on these large primer-template substrates (18).
We have developed a synthetic primer-template substrate for
evaluation of the kinetics and mechanism of 3Dpol-catalyzed
nucleotide incorporation (18). This substrate, referred to as
sym/sub-U (Fig. 2C), is a 10-nt self-complimentary RNA that
forms a 6-bp duplex and two 4-nt 5-overhangs capable of
templating correct incorporation of each of the four ribonucle-
otides. The “U” designation identifies the first templating base
of the substrate. Products can be resolved from substrate by
electrophoresis through denaturing polyacrylamide gels, de-
tected by phosphorimaging, and quantitated (Fig. 2C). Assem-
bly of 3Dpol onto sym/sub-U is slow, and the yield of assembled
complex is modulated by thermal inactivation (18). The rate
constant for assembly of G64S 3Dpol onto sym/sub-U is 3-fold
faster than WT 3Dpol; however, the yield of assembled com-
plexes is 2.5-fold lower than WT 3Dpol (Fig. 2D). These bio-
chemical defects were not predicted by the biological data,
which showed that G64S PV was capable of growing to titers
equivalent to WT PV (Fig. 1A).
FIG. 3. WT PV out-competes G64S PV. Percentage of WT PV (f)
and G64S PV () remaining after 0–3 serial passages. The initial virus
mixture contained a ratio of WT PV:G64S PV of 1:10.
FIG. 4. Assembled G64S 3Dpol-sym/sub complexes are stable and competent for nucleotide incorporation. A, steady-state incorpora-
tion of single (E) and multiple (●) nucleotides by WT 3D pol and G64S 3Dpol. The solid lines represent the fit of the data to a line. The y-intercept
is 0.88  0.02 M for AMP incorporation and 0.86  0.06 M for NMP incorporation by WT 3Dpol; the corresponding values for kcat (slope/y-intercept)
are 1.4  0.1  104 s1 for AMP incorporation and 1.2  0.1  103 s1 for NMP incorporation by WT 3Dpol. The y-intercept is 0.68  0.01 M
for AMP incorporation and 0.74  0.04 M for NMP incorporation by G64S 3Dpol; the corresponding values for kcat (slope/y-intercept) are 1.3  0.1 
104 s1 for AMP incorporation and 7.7  0.4  104 s1 for NMP incorporation by G64S 3Dpol. Reactions contained sym/sub (10 M duplex), 3Dpol
(1 M), and either ATP (500 M) or ATP, CTP, GTP, and UTP (500 M each). Reactions were initiated by addition of 3Dpol and quenched at the
indicated times by EDTA. B, stability of G64S 3Dpol-sym/sub complexes. Experimental design and kinetics of dissociation of 3Dpol-sym/sub
complexes for WT 3Dpol (●) and G64S 3D pol (E). The percentage of complex remaining competent for nucleotide incorporation is plotted as a
function of time. The solid lines represent the fit of the data to a single exponential with a kdiss(obs) of 5.0  0.6  10
4 s1 for WT 3Dpol and 7.0 
0.8 104 s1 for G64S 3Dpol. 3Dpol (1 M) was incubated with sym/sub (0.5 M duplex) for 90 s at which point trap, unlabeled sym/sub (100 M
duplex), was added to the reaction. At fixed times after the addition of trap, ATP (500 M) was added, and the reaction allowed to proceed for 30 s
and then quenched by addition of EDTA.
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G64S PV Exhibits Reduced Fitness Relative to WT PV—The
observation that G64S 3Dpol was not as robust as WT 3Dpol
in vitro suggested the possibility that fitness defects associated
with G64S PV had been overlooked by evaluating this virus in
isolation. Therefore, we created a mixed viral population con-
sisting of WT PV and G64S PV at a ratio of 1:10. The mixed
population was used to infect HeLa cells and serially passaged.
The ratio of each virus present at each stage of the experiment
was determined by sequencing. After the first passage, G64S
PV represented 20% of the virus population (Fig. 3). After the
second passage, G64S PV was barely detectable (Fig. 3). The
capacity of WT PV to out-compete G64S PV so efficiently shows
that G64S PV has a substantially reduced fitness relative to
WT PV.
G64S 3Dpol Exhibits Enhanced Fidelity of Nucleotide Incor-
poration—To determine whether the incorporation fidelity of
G64S 3Dpol is greater than WT 3Dpol, elongation complexes
must be evaluated. Although the yield of assembled G64S-
3Dpol-sym/sub-U complexes is reduced by 2.5-fold relative to
WT 3Dpol (Fig. 2D), this value could be increased to within 80%
of the value measured for WT 3Dpol by increasing the concen-
tration of sym/sub-U employed (y-intercept in Fig. 4A). The
rate-limiting step for single nucleotide incorporation under
steady-state conditions is dissociation of polymerase from sym/
sub-U product complex (18). WT 3Dpol dissociates faster from
the end of template (use of all four NTPs) than from internal
positions (use of ATP only) (Fig. 4A). G64S 3Dpol was competent
for single and multiple cycles of nucleotide incorporation, and
the corresponding steady-state rate constants for this enzyme
were equivalent to WT 3Dpol (Fig. 4A).
Because the steady-state analysis does not measure dissoci-
ation directly and provides information on the 3Dpol-sym/
sub-UA product complex rather than the 3Dpol-sym/sub-U sub-
strate complex, we performed the experiment shown in Fig. 4B.
G64S or WT 3Dpol was mixed with labeled sym/sub-U for 90 s
to permit complexes to form. Excess unlabeled sym/sub-U was
added as a trap for free and dissociating enzyme. ATP was
added at various times after addition of trap, and the reaction
was quenched 30 s later. The amount of complex remaining
was determined by determination of the amount of 11-mer
product formed. The rate constant for dissociation was deter-
mined by fitting the plot of the percentage of complex remain-
ing as a function of time to a single exponential decay. The rate
constants for dissociation are equivalent. Consistent with pre-
vious results, the stability of the 3Dpol-sym/sub-U substrate
complex was 	4-fold less stable than the 3Dpol-sym/sub-UA
product complex (18).
We evaluated the ATP concentration dependence of AMP
incorporation into sym/sub-U for the G64S and WT enzymes.
The results of this analysis are shown in Table I. The apparent
dissociation constant (Kd,app) for ATP is the same for both
enzymes. In contrast, there is a reduction of 	3-fold in the
maximal observed rate constant for nucleotide incorporation
(kpol) measured for the G64S enzyme relative to WT 3D
pol.
Importantly, the overall efficiency of RMP incorporation into
sym/sub-U by G64S 3Dpol is reduced by 5-fold relative to WT
3Dpol (Table I). Again, this difference is due to a reduction in
the observed rate constant for RMP incorporation without any
significant change in the value for the apparent dissociation
constant for RTP. Similarly, the overall efficiency of GMP in-
corporation into sym/sub-U by G64S 3Dpol is reduced by 4-fold.
We conclude that G64S 3Dpol has an increase in fidelity relative
to WT 3Dpol when nucleotides lacking canonical base pairing
capacity are employed.
FIG. 5. G64S 3Dpol is not blocked for elongation after incorporation of ribavirin. A, primer/template (sym/sub-U) employed. B,
experimental design. 3Dpol (2 M) was mixed with sym/sub (1 M duplex) for 3 min to assemble 3Dpol-sym/sub complexes after which RTP (1 mM)
or RTP (1 mM) and UTP (10 M) was added to the reaction. At fixed times after the addition of nucleotide the reaction was quenched by addition
of EDTA. C, denaturing PAGE of the 32P-labeled products from WT 3Dpol-catalyzed RMP incorporation into sym/sub-U. D, denaturing PAGE of the
32P-labeled products from G64S 3Dpol-catalyzed RMP incorporation into sym/sub-U.
TABLE I
G64S 3Dpol has a higher fidelity than WT 3Dpol in vitro
Experiments were performed as described under “Experimental Procedures.”
Nucleotide Enzyme Kd,app kpol kpol/Kd,app
(kpol/Kd,app)WT/(kpol/
Kd,app)G64S
M s1 M1 s1
ATP WT 130  20 90  5 0.65
G64S 160  10 30  5 0.20 3
RTP WT 390  40 1.0  0.2  102 2.8  105
G64S 370  40 2.0  0.2  103 5.7  106 5
GTP WT 330  50 1.5  0.2  102 4.5  105
G64S 320  50 3.5  0.2  103 1.1  105 4
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To rule out rate-limiting steps after incorporation of ribavirin
as an additional contributor to the decreased sensitivity of G64S
PV to ribavirin, we evaluated the kinetics of incorporation of
UMP after RMP incorporation by G64S 3Dpol and compared
these data to those obtained for WT 3Dpol (Fig. 5). UMP incorpo-
ration into sym/sub-U is undetectable in the absence of ribavirin,
but the kinetics of UMP incorporation are identical to the kinet-
ics of RMP incorporation when both RTP and UTP are present in
the reaction, suggesting that translocation does not become a
rate-limiting step after RMP incorporation by G64S or WT 3Dpol.
The final mechanism explored to explain the decreased sen-
sitivity of G64S PV to ribavirin was that G64S 3Dpol exhibited
biased incorporation opposite RMP in a template relative to
WT 3Dpol. To test this possibility, we employed sym/sub-UR,
which contains RMP as the second templating nucleotide (Fig.
6A). Elongation complexes were assembled by mixing 3Dpol,
sym/sub-UR, and ATP for 3 min to yield an 11-mer product
complex. Next, CTP or UTP was added for incorporation oppo-
site RMP, and GTP was also present in this mixture to evaluate
elongation of a C:R or U:R base pair (Fig. 6B). When CTP and
GTP are employed, a 14-mer product should accumulate; when
UTP and GTP are employed, a 13-mer product should accumu-
late. The expected products accumulate in reactions catalyzed
by either WT 3Dpol (Fig. 6C) or G64S 3Dpol (Fig. 6D). Relative
to WT 3Dpol, G64S 3Dpol shows a 2-fold decrease in the ob-
served rate of CMP (Fig. 6, compare E to F) and UMP (Fig. 6,
compare G to H) incorporation opposite RMP as well as a 2-fold
decrease in the observed rate of GMP incorporation after the
C:R or U:R base pair (Fig. 6, G and H). We conclude that biased
incorporation of CMP or UMP opposite RMP in the template
does not contribute to the increased tolerance of ribavirin by
G64S PV.
FIG. 6. G64S 3Dpol does not exhibit biased incorporation opposite ribavirin in the template. A, primer/template (sym/sub-UR)
sequences. B, experimental design. 3Dpol (2 M) was mixed with sym/sub (1 M duplex) and ATP (5 M) for 3 min to assemble 3Dpol-sym/sub product
complexes after which CTP (1 mM) and GTP (500 M) or UTP (1 mM) and GTP (500 M) was added to the reaction. At fixed times after the addition
of nucleotide the reaction was quenched by addition of EDTA. C, denaturing PAGE of the 32P-labeled products from WT 3Dpol-catalyzed nucleotide
incorporation into sym/sub-UR. D, denaturing PAGE of the 32P-labeled products from G64S 3Dpol-catalyzed nucleotide incorporation into
sym/sub-UR. E, kinetics of formation and disappearance of 12-mer (5 s1), 13-mer (12 s1), and 14-mer (50 s1) by WT with CTP and GTP. F,
kinetics of formation and disappearance of 12-mer (2.5 s1), 13-mer (5 s1), and 14-mer (50 s1) by G64S with CTP and GTP. G, kinetics of
formation and disappearance of 12-mer (1 s1) and 13-mer (10 s1) by WT with UTP and GTP. H, kinetics of formation and disappearance of 12-mer
(0.5 s1) and 13-mer (5 s1) by G64S with UTP and GTP.
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G64S 3Dpol Exhibits a Decrease in the Equilibrium Constant
for the Conformational Change Step Preceding Phosphoryl
Transfer—The kinetics of AMP incorporation into sym/sub-U
follows the five-step kinetic mechanism shown in Fig. 7A (7).
ATP binds to the 3Dpol-sym/sub-U complex, followed by an
isomerization step to form the catalytically competent complex.
Catalysis occurs followed by a second isomerization step and
pyrophosphate release. The observed reduction in the kpol val-
ues for G64S 3Dpol could therefore be a reflection of changes in
either step 2 or step 3.
In the presence of Mg2, both steps 2 and 3 are partially
rate-limiting for nucleotide incorporation for WT 3Dpol (Fig.
7A); however, in Mn2 step 3 is rate-limiting (7, 17). We eval-
uated the kinetics of AMP incorporation into sym/sub-U in the
presence of Mn2 (Fig. 7B). The values for the rate constant for
AMP incorporation for both enzymes are now within 30% of
each other (Fig. 7B). This observation points to step 2 as the
primary determinant for the decrease in the kpol value for G64S
in the presence of Mg2.
To obtain additional support for the conclusion that step 2 is
affected in the G64S derivative, we performed two additional
experiments. First, we evaluated the phosphorothioate effect;
that is, the efficiency of AMPS incorporation into sym/sub-U
relative to AMP incorporation into sym/sub-U. If the conforma-
tional change is more rate-limiting for the G64S enzyme, then
the value of kobs,ATP/kobs,ATPS (Eobs) should decrease for this
enzyme relative to WT 3Dpol (7). In the presence of Mg2, the
phosphorothioate effect for G64S was 3.2  0.2, whereas that
for WT was 4.2  0.4. In the presence of Mn2, the values for
the phosphorothioate effect were equivalent (Table II). The
elevated value of the phosphorothioate effect in the presence of
Mn2 is consistent with chemistry as the rate-limiting step for
nucleotide incorporation (17).
The second experiment performed exploited the observation
that reactions performed in the presence of Mn2 yield infor-
mation on the concentration of the isomerized ternary complex
and product complex when quenched by using EDTA and yield
information only on the product complex when quenched by
using HCl (17). These data yield results similar to isotope-
trapping experiments and can yield values for the equilibrium
constant across the conformational change step preceding
phosphoryl transfer (Kconf) and the rate constant for phospho-
ryl transfer (kchem) by using computer simulation to fit the data
to the mechanism shown in Fig. 7C. As shown in Fig. 7D, the
amplitude of the first phase of reactions quenched by using
EDTA is greater for WT 3Dpol than for G64S 3Dpol, suggesting
a decrease in the value of Kconf for the G64S enzyme. By
FIG. 7. The conformational change
step preceding phosphoryl transfer
is a fidelity checkpoint. A, complete
kinetic mechanism for WT 3Dpol-cata-
lyzed nucleotide incorporation in the
presence of Mg2. ERn (3D
pol-sym/sub
elongation complex); NTP (nucleotide);
ERnNTP (ternary complex); *ERnNTP
(activated ternary complex); *ERn1PPi
(activated product complex); ERn1PPi
(product complex); ERn1 (translocated
3Dpol-sym/sub product complex); PPi (py-
rophosphate). B, AMP incorporation into
sym/sub-U by WT 3Dpol (●) and G64S
3Dpol (E) in the presence of Mn2. The
solid lines represent the fit of the data to
a single exponential with a kobs of 27  2
s1 for WT 3Dpol and 19  1 s1 for G64S
3Dpol. 3Dpol (2 M) was incubated with
sym/sub (1 M duplex) and rapidly mixed
with ATP (1 mM) as described under “Ex-
perimental Procedures.” C, partial kinetic
mechanism employed for simulation of
the data shown below in panel D. D, ac-
cumulation of the activated ternary com-
plex prior to phosphoryl transfer. Kinetics
of AMP incorporation by WT 3Dpol and
G64S 3Dpol in the presence of Mn2
quenched by using either EDTA (●) or
HCl (E). The solid line represents the
simulation of the data to the mechanism
shown in panel C with values for Kconf and
kchem shown in Table II. EDTA-quench
data reflects *ERnNTP and *ERn1PPi;
HCl-quench data reflects *ERn1PPi only.
3Dpol (2 M) was incubated with sym/sub
(1 M duplex) and rapidly mixed with
ATP (1 mM) as described under “Experi-
mental Procedures.”
TABLE II






WT 3 30 8.3  0.9
G64S 1 30 8.9  0.5
a Kconf and kchem were determined by kinetic simulation of the data
shown in Fig. 7D to the mechanism shown in Fig. 7C.
b The observed phosphorothioate effect is calculated using (kobs)ATP/
(kobs)ATPS. The observed rate constant for nucleotide incorporation was
determined at a concentration of ATP (1 mM) or ATPS (1 mM) in the
presence of Mn2.
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simulating the data shown in Fig. 7D to the mechanism shown
in Fig. 7C, we obtain a value of 1 for Kconf (Table II) for G64S
3Dpol. This value is 3-fold lower than obtained for WT 3Dpol
(Table II) (17). Taken together, our kinetic analysis of correct
nucleotide incorporation catalyzed by the G64S 3Dpol suggests
that the 3-fold reduction in the observed rate constant for
nucleotide incorporation for this derivative relative to WT 3Dpol
is caused by a 3-fold reduction in the equilibrium constant
across the conformational change step preceding phosphoryl
transfer.
DISCUSSION
PV exists as a quasispecies with each viral genome contain-
ing 1–2 transition mutations introduced by the viral RdRp,
3Dpol, during genome replication as a result of the intrinsic
error rate of the polymerase (28). The quasispecies nature of
poliovirus, and RNA viruses in general, likely prevents viral
extinction when the viral population is challenged by antiviral
mechanisms of the host. A consequence of the existence as a
quasispecies is the enhanced sensitivity of the viral population
to accumulation of additional mutations (28–33). Therefore,
agents that increase the mutation frequency of the virus should
be effective antivirals. This prediction was not only confirmed
but also given clinical significance by studies of ribavirin that
showed that the mechanism of action of this antiviral is lethal
mutagenesis (24). Ribavirin triphosphate (RTP) is a substrate
for 3Dpol, and RMP is incorporated opposite both cytidine and
uridine in RNA templates (24).
In our initial report describing the mutagenic activity of
ribavirin, we suggested that resistance to lethal mutagens
would require a more faithful polymerase, which would not
likely emerge given the importance of a viral quasispecies for
virus survival (24). Nevertheless, we endeavored to isolate such
a mutant because of the insight this mutant could provide on
the biological and biochemical consequences of enhanced RdRp
fidelity and the kinetic and structural basis for polymerase
fidelity. We isolated a PV mutant with a single missense mu-
tation in 3Dpol-coding sequence that changed Gly-64 to Ser.
G64S PV was also isolated and reported earlier by Pfeiffer and
Kirkegaard (34). That study demonstrated reduced sensitivity
of G64S PV to ribavirin and other antiviral nucleosides in
tissue culture as well as a decrease in guanidine-resistant
variants in the G64S virus population.
G64S PV is, indeed, less sensitive to ribavirin (Fig. 1A).
However, this virus population is more sensitive to inhibitors of
uncoating (Fig. 1B). The enhanced sensitivity of G64S PV to
drugs that target the capsid is likely a reflection of the en-
hanced fidelity of G64S 3Dpol and the corresponding reduction
of drug-resistant variants in the population. This conclusion is
supported by direct sequencing of capsid-coding sequence,
which reveals a 4-fold reduction in mutation frequency (Fig.
1C). We have gone on to show that this reduced genomic diver-
sity of G64S PV leads to fitness decreases, restricted tissue
tropism, and attenuated pathogenesis by using a mouse model
for PV infection.2
Our initial biochemical experiments revealed enhanced ther-
mal inactivation of 3Dpol in vitro (Fig. 2A) that leads to reduced
poly(rU) polymerase activity (Fig. 2B) and a reduced yield of
stable elongation complexes on a synthetic primer-template
substrate (Fig. 2C). Such substantial defects in the biochemical
properties of G64S 3Dpol were unexpected, because G64S PV
grows to essentially the same titers as WT PV in the absence of
selection (Fig. 1A). It is possible that the temperature sensitiv-
ity of the mature G64S 3Dpol is not present in the context of the
precursor used to establish genome-replication complexes in
cells. However, these biochemical differences prompted a direct
evaluation of the fitness of G64S PV relative to WT PV by
performing a competition experiment in tissue culture. Sur-
prisingly, WT PV out-competed G64S PV after the first passage
under conditions in which the ratio of WT PV to G64S PV was
1:10 (Fig. 3).
Emergence of drug resistance to an antiviral therapy is a
major obstacle in the clinic. Therefore, the finding that PV can
develop resistance to ribavirin suggested that lethal mutagen-
esis may not be as effective as suggested by previous studies
(24, 28–30). However, the finding that two different groups
isolated the same ribavirin-resistant mutant suggests that
very few solutions exist to the problem of resistance to ribavirin
and, perhaps, other lethal mutagens. Indeed, as indicated by
the discussion above, G64S PV is one, not-so-good solution.
This lethal mutagen-resistant virus is less fit and more sensi-
tive to other drugs than WT PV, suggesting that application of
lethal mutagens in combination with other drugs should pre-
FIG. 8. A link between the fingers subdomain and conserved
structural motif A of the palm subdomain of PV 3Dpol. A, motif A
functions, in part, to orient the triphosphate of the incoming nucleotide
for catalysis. Model for interaction of 3Dpol with bound nucleotide (19,
20). ATP and metal ions required for catalysis are labeled. In this
model, the side chains for Asp-233 and Asp-238 have been rotated to
permit interactions with ATP. B, Gly-64 is located in the fingers sub-
domain. Complete structure for PV 3Dpol (22). The conserved structural
motifs in the palm subdomain are colored as follows: motif A, red; motif
B, green; motif C, yellow; motif D, blue; and motif E, purple. Van der
Waal’s projection of Gly-64 (orange). C, Gly-64 backbone orients the
amino terminus, and the amino terminus interacts with motif A. The
amino terminus of 3Dpol is in blue, Gly-64 is in orange, motif A is in red,
motif C is in yellow, and hydrogen bonds are shown as dashed lines.
Misalignment of position 64 will cause defects to the orientation of the
triphosphate as well as the efficiency of phosphoryl transfer owing to
misalignment of motif A.
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vent rapid development of resistance in a clinical setting. We
conclude that lethal mutagenesis remains a promising antivi-
ral strategy with limited potential for development of
resistance.
Once assembled, G64S 3Dpol-primer/template complexes are
as stable as complexes formed with WT 3Dpol (Fig. 4). Defects
to assembly can be overcome by increasing the concentration of
primer-template substrate employed (Fig. 4A). Assembled com-
plexes support fast rates of nucleotide incorporation (Table I)
and are competent for multiple cycles of nucleotide addition
(Figs. 4A and 5). Nucleotide binding by G64S 3Dpol is equiva-
lent to wild-type 3Dpol (Table I). Therefore, the only significant
defect to the elongation complex is a 3-fold reduction in
the observed rate constant (kpol) for nucleotide incorporation
(Table I).
Two steps in the kinetic mechanism dictate the observed rate
constant for nucleotide incorporation when Mg2 is employed
as the divalent cation cofactor: a conformational change step
preceding phosphoryl transfer (referred to as step 2) and phos-
phoryl transfer (referred to as step 3) (7). Because phosphoryl
transfer is the sole rate-limiting step when Mn2 is employed
as the divalent cation cofactor (17), the observation that the
observed rate constant for G64S 3Dpol-catalyzed nucleotide
incorporation in Mn2 was 70% of the value obtained for wild-
type 3Dpol in Mn2 (Fig. 7D) suggested that step 2 was affected
most by the G64S substitution. More thorough evaluation of
this step showed that the value for the equilibrium constant
across the conformational change step (Kconf) for G64S 3D
pol is,
indeed, reduced by 3-fold relative to WT 3Dpol (Table II and
Fig. 7D).
The destabilization of the catalytically competent ternary
complex appeared to be exacerbated by employing nucleotide
substrates incapable of forming a canonical base pairing geom-
etry, for example R:U and G:U base pairs, based upon the
reductions in the observed rate constants for RTP and GTP
utilization (Table I). The reduction in the observed rate con-
stant for RMP incorporation into sym/sub-U is clearly related
to Kconf for G64S 3D
pol, because this defect could not be rescued
by using Mn2 as the divalent cation cofactor (data not shown).
There is an ongoing debate regarding the importance of step 2
for polymerase fidelity (8, 9). The ability to show that an amino
acid substitution in 3Dpol that increases polymerase fidelity
causes a change in the value for Kconf provides an indisputable
link between step 2 and fidelity.
In addition to the controversy surrounding step 2 and fidel-
ity, there has been some debate regarding the molecular basis
of step 2 (15, 16). Crystal structures of polymerase ternary
complexes have been used to argue that step 2 reflects inter-
domain rearrangements that convert the catalytic site from an
“open” to a “closed” conformation in response to nucleotide
binding (10–12). More recently, additional rearrangements
have been observed in DNA and RNA polymerase structures
after formation of the “closed” conformation that permit the
triphosphate moiety of the incoming nucleotide to achieve a
catalytically competent conformation (16, 38, 39). For the
RdRp, we have argued that step 2 reflects reorientation of the
triphosphate into a catalytically competent conformation (7), a
process that would occur after formation of the closed complex.
This interpretation creates an inextricable link between step 2
and the observed rate constant for phosphoryl transfer. Desta-
bilization of the active conformation of the triphosphate would
reduce the frequency of molecules in an optimal position for
attack by the 3-OH of the primer terminus.
The active conformation of the triphosphate of all poly-
merases relies on interactions between the phosphate and two
divalent cations, in most cases magnesium ions. The divalent
cations are also coordinated by carboxylates originating from
aspartic acid residues conserved in all polymerases. An estab-
lished model of this interaction for 3Dpol is shown in Fig. 8A
(19, 20). Structural motif A consists of residues 233–241. Asp-
233 is a ligand to the metal, Asp-238 interacts with the ribose
of the incoming nucleotide and the backbone in between these
residues participates in hydrogen bonding interactions that
stabilize the active conformation of the triphosphate. There-
fore, perturbations of motif A should alter the equilibrium
position of the triphosphate. Based on the discussion above, a
change in the equilibrium position of the triphosphate should
be manifested as a change in Kconf for step 2.
FIG. 9. Triphosphate reorientation
as a fidelity checkpoint in all poly-
merases. A, Bacillus stearothermophilus
DNA polymerase I fragment. The panel
on the left was derived from 1L3U (16).
We inserted a dCTP molecule to maintain
interaction between the triphosphate and
the basic amino acids of the O helix. The
panel on the right was derived from 1LV5
(16). B, T7 RNA polymerase. The panel on
the left was derived from 1S0V (38). The
panel on the right was derived from 1S76
(39). In both polymerases, two conforma-
tions of the incoming nucleotide can be
observed. Complexes on the right are
poised for catalysis. We propose that
these two complexes represent ERnNTP
and *ERnNTP observed as the first fidel-
ity checkpoint in the kinetic mechanism
for PV 3Dpol (Fig. 7A), suggesting that
this checkpoint is conserved in all classes
of nucleic acid polymerases with a canon-
ical, palm-based active site.
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Gly-64 is located in the fingers domain (Fig. 8B). At first
glance, it would appear that this residue is remote from the
catalytic center. However, upon inspection of the structure for
3Dpol (22), it becomes clear that a direct link exists between
position 64 and motif A. The backbone of Gly-64 is hydrogen-
bonded to the amino terminus, which, in turn, is hydrogen-
bonded to the backbone of residues Ala-239 and Leu-241 of
motif A (Fig. 8C). In order for the backbone of Gly-64 to achieve
interactions with the amino terminus, this residue has to as-
sume a conformation that is disallowed in the Ramachandran
plot (22). Therefore, Ser at this position would preclude an
optimal interaction between the position-64 backbone and the
amino terminus with negative consequences on the position of
motif A and stabilization of the triphosphate. We conclude that
the conformational change preceding chemistry is orientation
(kconf) and stabilization (kconf) of the triphosphate in the
active conformation and serves as the first fidelity checkpoint
in the kinetic mechanism for RdRp-catalyzed nucleotide
incorporation.
The use of triphosphate reorientation and stabilization of the
isomerized triphosphate as a fidelity checkpoint can also be
extrapolated to DNA-dependent DNA and RNA polymerases.
Structural data available for DNA polymerase I from Bacillus
stearothermophilus (BF) (Fig. 9A) and the RNA polymerase
from bacteriophage T7 (T7 Rp) (Fig. 9B) show similar rear-
rangements of the triphosphate during a nucleotide addition
cycle (16, 38, 39). In both cases, there is an initial interaction of
the triphosphate with helix O that collapses into the active
conformation. The active conformation is characterized by an
interaction of the triphosphate with a divalent cation, which, in
turn, is interacting with a conserved aspartic acid. This aspar-
tic acid is equivalent to Asp-233 in 3Dpol (Asp-653 in BF and
Asp-537 in T7 Rp). Binding of a nucleotide with an incorrect
base or sugar configuration would prevent maximal stabiliza-
tion of the isomerized triphosphate, causing a reduced effi-
ciency of incorporation and shifting the overall equilibrium of
the reaction in the direction of nucleotide release to provide an
opportunity for binding of another nucleotide.
Mutational analysis of residues in helix O has established a
role for this helix in DNA polymerase fidelity; however, precise
kinetic and structural explanations are lacking (40–42). Tyr-
639 is located at the end of helix O in T7 Rp and modulates
sugar specificity, again without a clear molecular explanation
(43). We suggest that mutations in helix O change the equilib-
rium position of the triphosphate, leading to decreases in the
efficiency of correct nucleotide incorporation without substan-
tial changes for incorrect nucleotides, the combination of which
accounts for the observed reduction in fidelity.
The connection between the fingers and motif A observed in
PV 3Dpol is not only conserved in other picornavirus poly-
merases, for example human rhinovirus (Fig. 10A), but also in
other supergroup I polymerases, for example Norwalk virus
(Fig. 10B), and supergroup II polymerases, for example hepa-
titis C virus (Fig. 10C). We conclude that control of fidelity by
sites remote from the catalytic center as demonstrated here for
PV 3Dpol is a conserved feature in all RdRps. Although the
picornavirus polymerases employ the amino terminus for in-
teractions with motif A, an arginine serves this purpose in the
other enzymes (Fig. 10). In all cases, the region of the fingers in
contact with motif A is solvent-accessible. Small molecules that
interact with this surface could cause changes in polymerase
activity that range from increased or decreased fidelity to com-
plete inactivation. Any of these outcomes should lead to a
significant antiviral effect. The capacity of small molecules to
target remote sites of a polymerase and interfere with incorpo-
ration at the active site has been shown recently by the design
of a new class of inhibitors effective against Escherichia coli
RNA polymerase (44).
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